NCT00057863View on ClinicalTrials.gov

Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

December 31, 2009

Study Completion Date

March 31, 2010

Conditions
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell CarcinomaRecurrent Cervical CarcinomaStage IVA Cervical CancerStage IVB Cervical Cancer
Interventions
DRUG

Paclitaxel

Given IV

DRUG

Oxaliplatin

Given IV

Trial Locations (1)

10467-2490

Montefiore Medical Center - Moses Campus, The Bronx

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00057863 - Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer | Biotech Hunter | Biotech Hunter